NCT07915336Enrolling by invitation
Peer Ambassador in Gyn Onc Trials
Peer Ambassador in Gynecologic Oncology Clinical Trials
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
The goal of this study is to learn if peer ambassador support will increase clinical trial enrollment in patients with ovarian cancer. Participants will participate in a peer ambassador program where a patient ambassador (mentor) will be paired with a mentee. The patient ambassador will be a patient with history of cancer who has participated in a clinical trial and can serve as an ambassador to facilitate discussions regarding education and awareness of clinical trials.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- First submitted
- 17 Sept 2026
- Start date
- 30 Oct 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- Diseases
- Ovarian cancer
- NCT number
- NCT07915336
What you commit to
- Study type: Interventional
- Planned participants: 125
- From 30 Oct 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Mentees Inclusion Criteria:
- any patient with ovarian cancer who has never participated in a clinical trial
- Ambassadors Inclusion Criteria:
- any patient who has participated in an interventional clinical trial
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.